Menczer J, Ben-Shem E, Golan A, Levy T
Gynecologic Oncology Unit, Department of Obstetrics and Gynecology, E. Wolfson Medical Center Holon, Tel Aviv University, Sackler Faculty of Medicine, Tel Aviv, Israel.
Eur J Gynaecol Oncol. 2013;34(6):545-7.
To assess the prevalence of leiomyomas in patients with endometrial carcinoma (EC) and the association of their presence with clinico-pathological variables and with survival.
A retrospective chart review was conducted of all endometrial carcinoma (EC) patients diagnosed and treated in the present institution between 2002 and 2008. Selected clinical data were abstracted from medical records. Pathological data such as the presence of myomas (any size), tumor grade, depth of myometrial invasion presence of lymphovascular space involvement (LVSI), and the presence of metastases, are based on the original pathology report.
Coexisting myomas were found in 74 (56.9%) of 130 EC patients diagnosed during the study period. No significant difference with regard to age, histological type, stage, grade, depth of myometrial invasion, LVSI, lymph node involvement, and presence of metastases (other than lymph node involvement) was found between patients without and with myomas. There was also no significant difference in survival of EC patients without and with coexistent myomas.
The present data seem to indicate that the presence of myomas does not affect clinico-pathological variables of EC patients nor their survival.
评估子宫内膜癌(EC)患者中平滑肌瘤的患病率,以及平滑肌瘤的存在与临床病理变量和生存率之间的关联。
对2002年至2008年期间在本机构诊断和治疗的所有子宫内膜癌(EC)患者进行回顾性病历审查。从病历中提取选定的临床数据。病理数据,如肌瘤(任何大小)的存在、肿瘤分级、肌层浸润深度、淋巴管间隙浸润(LVSI)的存在以及转移的存在,均基于原始病理报告。
在研究期间诊断的130例EC患者中,有74例(56.9%)发现并存肌瘤。在无肌瘤和有肌瘤的患者之间,在年龄、组织学类型、分期、分级、肌层浸润深度、LVSI、淋巴结受累以及转移的存在(除淋巴结受累外)方面未发现显著差异。无并存肌瘤和有并存肌瘤的EC患者的生存率也无显著差异。
目前的数据似乎表明,肌瘤的存在不影响EC患者的临床病理变量及其生存率。